Allergy

The Pharmacy Times® Allergy resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?

Monday Pharmaceutical Mystery: April 15

Why is this patient listing ciprofloxacin as an allergy?

Helping Patients Breathe Easier

Pharmacists have a great opportunity to educate patients about how to stay healthy and counsel those in need of symptom relief about their allergy treatment options.

Here Comes Allergy Season

Pharmacists can provide easily accessible and economically reasonable solutions for patients who suffer from allergies.

FDA OKs Dupilumab For Adolescent AD

Dupilumab is now the first biologic therapy approved for the patient population.

Inhalers are Used Incorrectly by Majority of Patients With Asthma

Inhaler misuse may result in more asthma attacks.

Immunotherapy Leads to Some Being Able to Consume Eggs Up to 5 Years Later

Future studies will help us determine who will most benefit from egg oral immunotherapy.

Intranasal Epinephrine Spray Granted Fast Track Designation

The needed-free treatment option, ARS-1, is designed to be easy-to-use, convenient and more reliable than other emergency epinephrine treatments for severe allergic reactions.

Newly Approved Generic Version of EpiPen Is Not Cheaper Than Available Option

Teva’s Epinephrine Injection May Not Undercut Mylan’s on Price, but It Could Help in Addressing Shortages

A Guide to the Proper Use of Nonprescription Decongestant Products

Nasal congestion can negatively affect quality of life by interfering with day-to-day activities and disrupting sleep patterns.

Positive Topline Results Shown for Dupilumab in Phase 3 Trials in Patients with CRSwNP

A pair of pivotal Phase 3 placebo-controlled trials that evaluated dupilumab (Dupixent, Sanofi and Regeneron) for adults with inadequately-controlled chronic rhinosinusitis with nasal polyps met all primary and secondary endpoints.

Misreported Penicillin Allergies Lead to Increased Risk of Infection, Antibiotic Resistance

National Penicillin Allergy Day highlights negative impact of Inaccurate allergy diagnoses.

FDA: Mix-up Prompts Montelukast Sodium Tablet Recall

One lot of Montelukast Sodium Tablets is being voluntarily recalled by Camber Pharmaceuticals, due to a safety risk for consumers.

The Pharmacy Times® Allergy resource center serves as the heart of all clinical news and articles related to allergies. The coverage includes updates from the floor of all the biggest societal conferences and annual meetings, as well as video interviews of the leading experts and key opinion leaders in allergy.

Among the multimedia content are breaking news coverage of approvals from the US Food and Drug Administration, key takeaways from the latest novel therapies in clinical trials, and notifications of updates to clinical guidelines for countless conditions. Additionally, this resource provides multiple allergen-specific resources, ranging from food and drug to environment and contact-based allergies.